Wegovy UK Price 2026: Cheapest Options, How Much It Costs Per Month, and the New Wegovy Pill

June 22, 2026 George 0 Comments

Most people searching for Wegovy prices in the UK get one of two answers: an NHS price that is nearly impossible to access, or private prices that vary so widely between providers that comparison is almost impossible.

Here is the honest picture as of June 2026: Wegovy injections cost £80–£299 per month privately depending on your dose and provider. On the NHS, it costs £9.90 per prescription in England (free in Scotland, Wales, and Northern Ireland) — but getting there requires a GP referral, strict eligibility criteria, and waiting lists that can stretch to 6–18 months or longer. And as of 11 June 2026, there is now a Wegovy pill approved by the MHRA, priced from around £99–£249 per month privately.

Here is what you will actually pay, how the NHS and private routes compare, what the new pill option means, and how to buy safely.

Wegovy UK Price at a Glance (June 2026)

Route	Monthly Cost	Notes
NHS prescription (England)	£9.90 per item	Via Tier 3 specialist service only — not GP direct
NHS prescription (Scotland/Wales/NI)	Free	Via Tier 3 specialist service only
Private injection — starter dose (0.25mg)	£80–£149/month	Lower doses during titration phase
Private injection — maintenance dose (2.4mg)	£189–£299/month	Most people reach this after 16–20 weeks
Wegovy pill — private (MHRA approved June 2026)	£99–£249/month	Not yet available on NHS — NICE review needed
Annual private cost (injection, full year)	£1,800–£3,600	Medication only; excludes consultation and delivery fees

Wegovy Injection: Private Price Breakdown by Provider

Private Wegovy injection pricing in the UK varies considerably because pharmacies set their own prices on top of the cost of the medicine from Novo Nordisk. As of June 2026, the indicative private price ranges across UK providers are:

Dose	Titration Stage	Price Range/Month	Notes
0.25mg	Weeks 1–4	£80–£149	Starting dose — cheapest point of treatment
0.5mg	Weeks 5–8	£100–£169	Second titration step
1mg	Weeks 9–12	£120–£199	Mid-titration
1.7mg	Weeks 13–16	£149–£239	Near maintenance
2.4mg	Week 17+	£189–£299	Full maintenance dose — ongoing monthly cost

Important: these are medication costs only. Many providers charge separately for the initial clinical consultation (typically £50–£150), follow-up prescription reviews (£30–£100 per appointment), and delivery. Some providers bundle everything into a single monthly fee — compare total costs, not just the headline medication price.

Current promotions worth checking: Numan (£94 off first month), Superdrug Online Doctor (15% off with code MYFRIDAY as of June 2026), Phlo (£30 off starter dose). Always verify these directly — promotions change frequently.

The Wegovy Pill: MHRA Approved June 2026

On 11 June 2026, the MHRA (Medicines and Healthcare products Regulatory Agency) approved oral semaglutide — the Wegovy pill — for weight management in the UK. This is a significant development: it is the first GLP-1 weight loss tablet approved in the UK, removing the need for weekly injections for patients who prefer or require an oral route.

Wegovy pill pricing in the UK as of June 2026:

Chemist4U: from £99/month (starter doses 1.5mg and 4mg) rising to £199/month at maintenance (25mg)
Asda Online Doctor (via ZAVA): from £98.97/month at starter dose to £188.97/month at maintenance
Numan: from £129/month starter to £249/month at maintenance
Simple Online Pharmacy: from £99/month (injections) — pill pricing aligns similarly

Important caveats on the Wegovy pill:

NHS access is not yet available — NICE must complete a separate review before NHS funding is confirmed. This is unlikely before 2027 at the earliest.
Not all providers have the pill in stock yet — some are offering pre-orders for early summer 2026 delivery
The pill requires specific fasting conditions before each dose — check the prescribing guidance

The MHRA’s official announcement about oral Wegovy approval is at gov.uk/government/news/first-glp-1-tablet-for-weight-loss-approved-in-the-uk — the definitive source for regulatory status.

NHS Wegovy: Who Qualifies and How to Get It

Wegovy is available on the NHS, but access is tightly controlled through specialist weight management services — not your GP surgery directly. Your GP can refer you, but cannot prescribe Wegovy themselves under the current NHS pathway.

NHS Eligibility Criteria for Wegovy

BMI of 35 or above with at least one weight-related health condition (high blood pressure, type 2 diabetes, cardiovascular disease, obstructive sleep apnoea, or non-alcoholic fatty liver disease)
BMI of 32.5 or above for people of Asian, Chinese, Middle Eastern, Black African or African-Caribbean origin (lower threshold reflects higher cardiovascular risk at lower BMI)
BMI of 30 or above with type 2 diabetes — Wegovy is also NICE-recommended to reduce cardiovascular risk in this group following the SELECT trial
Evidence that previous lifestyle interventions (diet and exercise programmes) have not been sufficient
Referral from your GP to a Tier 3 specialist weight management service

The NHS Waiting List Reality

Even if you meet all eligibility criteria, NHS Wegovy access is not quick. Tier 3 weight management waiting lists vary enormously by region — from approximately 6 months in some areas to 18 months or longer in others. Many integrated care boards have paused new initiations or restricted access due to supply constraints and service capacity. NHS treatment is also capped at a maximum of two years.

Practical approach: if you are considering Wegovy and meet NHS criteria, ask your GP to start the referral process now — even if you intend to start privately in the meantime. Some patients begin on private prescriptions and transition to NHS treatment once their Tier 3 appointment comes through.

Buying Wegovy Safely: What to Check Before You Order

The MHRA has issued active warnings about counterfeit semaglutide sold online. Fake Wegovy pens have been found containing dangerous substances. Only buy from regulated UK providers.

Before ordering from any online provider, check:

GPhC registration: verify the pharmacy’s registration number on the General Pharmaceutical Council register at pharmacyregulation.org
CQC registration: the prescribing service must be registered with the Care Quality Commission (England) — check at cqc.org.uk
Distance-selling logo: legitimate online pharmacies display this logo, which links to their NHS registration
GP notification: your provider should inform your GP of any private prescription issued

If you are also considering NHS support routes, see our full guide to the NHS weight management programme and Tier 3/Tier 4 referral process which covers what happens at each stage of the NHS pathway.

Wegovy vs Mounjaro: Which Is Cheaper?

Mounjaro (tirzepatide) is the main competitor to Wegovy in the UK private market. As of June 2026, their pricing is broadly similar at maintenance doses — both typically cost £189–£299 per month privately at the highest doses. Mounjaro has shown slightly higher average weight loss in head-to-head trial data (SURMOUNT-5 published 2024), but both are effective GLP-1 class medications. The choice between them should be made with a prescriber based on your individual health profile, not price alone.

Is Wegovy Worth the Cost?

Clinical trial data shows that Wegovy (semaglutide 2.4mg) produces an average weight loss of approximately 14.9% of body weight over 68 weeks — significantly more than diet and exercise alone. The SELECT trial also demonstrated a 20% reduction in major cardiovascular events in adults with obesity and existing heart disease, which prompted expanded NICE guidance.

Whether the private cost is worth it depends on individual circumstances. At £200–£300 per month for potentially two or more years, the total cost can reach £4,800–£7,200 — a significant financial commitment. Many people find the results meaningful enough to justify the cost; others find that accessing NHS support or using lower-cost alternatives (including orlistat, which is available over the counter for around £20–£50 per month) is more appropriate for their situation.

This is a decision to make with your GP or a registered prescriber, not based on online research alone.

Bottom Line


✅ Private injection cost	£80–£149/month starter; £189–£299/month at 2.4mg maintenance
✅ Wegovy pill (June 2026)	MHRA-approved; from £99–£249/month privately; not yet on NHS
✅ NHS cost	£9.90/prescription (England); free (Scotland/Wales/NI)
✅ NHS eligibility	BMI 35+ with weight-related condition; GP referral to Tier 3 required
✅ NHS waiting time	6–18+ months depending on region
✅ Safety warning	Only buy from GPhC-registered pharmacy + CQC-registered prescriber — MHRA warns of counterfeit semaglutide

Frequently Asked Questions

What is the cheapest place to buy Wegovy in the UK?

As of June 2026, starter-dose Wegovy injection prices begin at around £80–£99 per month through providers such as Simple Online Pharmacy and Chemist4U. For the Wegovy pill (MHRA-approved June 2026), Asda Online Doctor (via ZAVA) and Chemist4U both offer starting doses from approximately £99 per month. Always compare total costs including consultation and delivery fees, not just the headline medication price.

How much does Wegovy cost per month in the UK?

Private Wegovy injection costs range from £80–£149 per month at the starting 0.25mg dose to £189–£299 per month at the 2.4mg maintenance dose. The Wegovy pill costs from approximately £99–£249 per month. Annual private treatment costs typically total £1,800–£3,600 for the injection. NHS treatment costs £9.90 per prescription in England and is free in Scotland, Wales, and Northern Ireland, but access requires a Tier 3 referral.

Is Wegovy available on the NHS?

Yes, but access is strictly limited. You need a GP referral to a Tier 3 specialist weight management service, a BMI of 35 or above with a weight-related health condition (or 32.5+ for some ethnic groups), and evidence that previous lifestyle interventions have not been sufficient. Waiting lists can be 6–18 months or longer in many areas. The Wegovy pill approved in June 2026 is not yet available on the NHS.

What is the Wegovy pill and when was it approved in the UK?

The Wegovy pill (oral semaglutide) was approved by the MHRA on 11 June 2026 — the first GLP-1 weight loss tablet approved in the UK. It contains the same active ingredient as the Wegovy injection but is taken orally rather than by injection. Private prices start from approximately £99 per month. NHS access requires a separate NICE review and is unlikely before 2027.

How do I know if a Wegovy provider is legitimate?

Check that the pharmacy has a GPhC (General Pharmaceutical Council) registration number — verify it at pharmacyregulation.org. The prescribing service must also be CQC-registered (Care Quality Commission) in England. Legitimate providers display the distance-selling logo linking to their NHS registration. The MHRA has warned about counterfeit semaglutide sold online — never buy from unverified sources or social media.